TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 47 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $30,000 | +66.7% | 38,000 | +111.1% | 0.00% | – |
Q2 2022 | $18,000 | 0.0% | 18,000 | 0.0% | 0.00% | – |
Q1 2022 | $18,000 | 0.0% | 18,000 | 0.0% | 0.00% | – |
Q4 2021 | $18,000 | +20.0% | 18,000 | +20.0% | 0.00% | – |
Q3 2021 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q2 2021 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q1 2021 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q4 2020 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q3 2020 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q2 2020 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q1 2020 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q4 2019 | $15,000 | +7.1% | 15,000 | 0.0% | 0.00% | – |
Q3 2019 | $14,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q2 2019 | $14,000 | -6.7% | 15,000 | 0.0% | 0.00% | – |
Q1 2019 | $15,000 | +7.1% | 15,000 | 0.0% | 0.00% | – |
Q4 2018 | $14,000 | -6.7% | 15,000 | 0.0% | 0.00% | – |
Q3 2018 | $15,000 | 0.0% | 15,000 | 0.0% | 0.00% | – |
Q2 2018 | $15,000 | -16.7% | 15,000 | -21.1% | 0.00% | – |
Q1 2018 | $18,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q4 2017 | $18,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q3 2017 | $18,000 | -5.3% | 19,000 | 0.0% | 0.00% | – |
Q2 2017 | $19,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q1 2017 | $19,000 | -5.0% | 19,000 | 0.0% | 0.00% | – |
Q4 2016 | $20,000 | -13.0% | 19,000 | 0.0% | 0.00% | – |
Q3 2016 | $23,000 | -8.0% | 19,000 | 0.0% | 0.00% | – |
Q2 2016 | $25,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q1 2016 | $25,000 | -39.0% | 19,000 | -26.9% | 0.00% | – |
Q4 2015 | $41,000 | +64.0% | 26,000 | +36.8% | 0.00% | – |
Q3 2015 | $25,000 | -7.4% | 19,000 | 0.0% | 0.00% | – |
Q2 2015 | $27,000 | -3.6% | 19,000 | 0.0% | 0.00% | – |
Q1 2015 | $28,000 | +7.7% | 19,000 | 0.0% | 0.00% | – |
Q4 2014 | $26,000 | +8.3% | 19,000 | 0.0% | 0.00% | – |
Q3 2014 | $24,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q2 2014 | $24,000 | 0.0% | 19,000 | 0.0% | 0.00% | – |
Q1 2014 | $24,000 | -36.8% | 19,000 | -47.2% | 0.00% | -100.0% |
Q4 2013 | $38,000 | +90.0% | 36,000 | +89.5% | 0.00% | 0.0% |
Q3 2013 | $20,000 | 0.0% | 19,000 | 0.0% | 0.00% | 0.0% |
Q2 2013 | $20,000 | – | 19,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Arena Capital Advisors, LLC- CA | 68,443,000 | $68,785,000 | 10.97% |
PIPER SANDLER & CO. | 12,550,000 | $12,425,000 | 8.95% |
Radcliffe Capital Management, L.P. | 100,783,000 | $100,279,000 | 6.28% |
INCOME RESEARCH & MANAGEMENT | 14,775,000 | $14,701,000 | 5.39% |
PenderFund Capital Management Ltd. | 4,000,000 | $5,123,000 | 1.30% |
Bracebridge Capital, LLC | 5,500,000 | $5,390,000 | 0.82% |
Western Asset Management Company, LLC | 9,000,000 | $8,916,000 | 0.57% |
WESTWOOD HOLDINGS GROUP INC | 43,125,000 | $42,856,000 | 0.49% |
CORBYN INVESTMENT MANAGEMENT INC/MD | 1,050,000 | $1,045,000 | 0.45% |
JUPITER ASSET MANAGEMENT LTD | 35,000,000 | $34,675,000 | 0.35% |